← Back to Search

Behavioral Intervention

MAAPS Intervention for Autism (MAAPS Trial)

N/A

Recruiting

Led By Cynthia Anderson, PhD, BCBA-D-D

Research Sponsored by May Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, approximately 6 months after baseline, approximately 9 months after baseline

Awards & highlights

MAAPS Trial Summary

This trial is testing whether MAAPS, an intervention system for elementary students with autism, improves teacher outcomes and student educational outcomes.

Who is the study for?

This trial is for elementary school children (K-6th grade) with an educational classification of autism spectrum disorder, attending public school in person at least once a week. Their parents/guardians and teachers must consent to participate. Children with motor disabilities like cerebral palsy, genetic disorders associated with ASD, or profound vision/hearing loss cannot join.Check my eligibility

What is being tested?

The Modular Approach for Autism Programs in Schools (MAAPS) is being tested to see if it improves teacher strategies and student outcomes compared to usual services. MAAPS uses evidence-based methods tailored to help students with ASD succeed in elementary schools.See study design

What are the potential side effects?

Since MAAPS is an educational intervention system rather than a medical treatment, it does not have physical side effects. However, there may be adjustments needed as teachers and students adapt to the new approach.

MAAPS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, approximately 6 months after baseline, approximately 9 months after baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, approximately 6 months after baseline, approximately 9 months after baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, approximately 6 months after baseline, approximately 9 months after baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in engaged time measured by Academic Engaged Time (AET)

Change in rating for Teacher Nominated Target Problems (TNTP)

Change in score for Adaptive Behavior Assessment System, Third Edition (ABAS-3)

+4 more

Secondary outcome measures

Usage Rating Profile-Intervention, Revised (URP-IR)

MAAPS Trial Design

2Treatment groups

Active Control

Group I: MAAPSActive Control1 Intervention

Modular intervention system integrating evidence-based strategies to address core and associated features of ASD and ongoing coaching.

Group II: Waitlist controlActive Control1 Intervention

Services as usual.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

May InstituteLead Sponsor

2 Previous Clinical Trials

128 Total Patients Enrolled

2 Trials studying Autism Spectrum Disorder

128 Patients Enrolled for Autism Spectrum Disorder

University of South FloridaOTHER

412 Previous Clinical Trials

186,939 Total Patients Enrolled

12 Trials studying Autism Spectrum Disorder

907 Patients Enrolled for Autism Spectrum Disorder

University of RochesterOTHER

840 Previous Clinical Trials

534,130 Total Patients Enrolled

11 Trials studying Autism Spectrum Disorder

9,469 Patients Enrolled for Autism Spectrum Disorder

Media Library

MAAPS (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04533607 — N/A

Autism Spectrum Disorder Research Study Groups: MAAPS, Waitlist control

Autism Spectrum Disorder Clinical Trial 2023: MAAPS Highlights & Side Effects. Trial Name: NCT04533607 — N/A

MAAPS (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04533607 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the cutoff age for this trial participants 40 years or older?

"This medical study is accepting participants who are between the ages of 5 and 12 years old."

Answered by AI

Is there any availability for participants in this research project?

"Indeed, clinicaltrials.gov's data verifies that this experiment is currently seeking volunteers. It was first made accessible on November 4th 2020 and has been recently updated on February 22nd 2021. The trial requires 120 subjects to be recruited across 3 research sites."

Answered by AI

What criteria must be met for someone to qualify as a participant in this trial?

"This medical trial is recruiting 120 individuals diagnosed with autism spectrum disorder whose age ranges between 5 and 12. Notably, potential participants are expected to comply with the following criteria: no changes in school placement or core team members during the upcoming academic year; attending a public elementary school (K-6th grade); being present in-person at least once per week; child's teacher consents to their participation."

Answered by AI

What is the approximate participant count of this experiment?

"This study requires 120 participants that meet its pre-set conditions to sign up. Potential enrollees can access this medication through the May Institute in Randolph, Massachusetts or University of Rochester in Rochester, New york."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Modular Approach for Autism Programs in Schools

Cynthia Anderson 2020. "Modular Approach for Autism Programs in Schools". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04533607.

All > Asd > Autism